Date: {{$ActivityAssignDate}}

Dear Dr. {{ $doctorName }},


Subject: SurveY to assess multifactorial approach for reductioN in risk of complications in diabEtes based on Routine manaGement strategY among healthcare practitioners (SYNERGY)


The number of patients with diabetes and prediabetes in India is 101 million and 136 million, respectively. The burden of diabetes is much higher than earlier reported figures. Type 2 diabetes mellitus (T2DM) is due to the progressive loss of β-cell insulin secretion frequently on the background of insulin resistance. Long term glycemic control plays a vital role in the prevention of complication of diabetes.


Along with exercise and diet oral antidiabetic drugs play a key role in the control of glycemia in diabetic patients. The American Diabetes association standard of care guidelines 2024 recommends early combination therapy to be considered at treatment initiation to shorten the time to attain the individualised glycemic goals. Multifactorial treatment is simultaneous management of all trackable risk factors like lifestyle adaptation together with glycaemic, blood pressure and lipid control.


There is a good quality evidence on the legacy benefits of multifactorial risk factor interventions on renal, cardiovascular and mortality outcomes. Despite this robust evidence, therapeutic inertia is widespread in the management of these risk factors in clinical practice.


This multicenter survey is planned to get insights in the management practices in diabetic patients among healthcare practitioners and to get insights on multifactorial approach for reduction in risk of complications in diabetic patients.


We invite you to participate in this survey. On acceptance, you will need to fill the survey questionnaire form provided.


We would encourage you to carefully fill all available information to the fullest in the questionnaire.


If you agree to participate in the said survey, we would request you to sign and return the enclosed reply along with your visiting card for accuracy of records.


Yours truly,

Ms. Seema Samant

Sun Pharma Laboratories Limited

Sun House, 201/B1,

Western Express Highway,

Goregaon (East), Mumbai,

Maharashtra (India) – 400 063